Cargando…

p53-independent p21 induction by MELK inhibition

MELK play critical roles in human carcinogenesis through activation of cell proliferation, inhibition of apoptosis and maintenance of stemness. Therefore, MELK is a promising therapeutic target for a wide range of cancers. Although p21 is a well-known p53-downstream gene, we found that treatment wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuda, Tatsuo, Kato, Taigo, Kiyotani, Kazuma, Tarhan, Yunus Emre, Saloura, Vassiliki, Chung, Suyoun, Ueda, Koji, Nakamura, Yusuke, Park, Jae-Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601624/ https://www.ncbi.nlm.nih.gov/pubmed/28938528 http://dx.doi.org/10.18632/oncotarget.18488

Ejemplares similares

p21 can be a barrier to ferroptosis independent of p53
por: Venkatesh, Divya, et al.
Publicado: (2020)

Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma
por: Ren, Lili, et al.
Publicado: (2019)

Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer
por: Inoue, Hiroyuki, et al.
Publicado: (2016)

Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown()
por: Tarhan, Yunus Emre, et al.
Publicado: (2016)

Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer
por: Chung, Suyoun, et al.
Publicado: (2012)

SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells
por: Vougiouklakis, Theodore, et al.
Publicado: (2015)

p53 and rapamycin are additive
por: Christy, Barbara, et al.
Publicado: (2015)

Identification of a p53-repressed gene module in breast cancer cells
por: Miyamoto, Takafumi, et al.
Publicado: (2017)

Phosphorylation of Tip60 by p38α regulates p53-mediated PUMA induction and apoptosis in response to DNA damage
por: Xu, Yingxi, et al.
Publicado: (2014)

Phosphatidylinositol glycan anchor biosynthesis, class X containing complex promotes cancer cell proliferation through suppression of EHD2 and ZIC1, putative tumor suppressors
por: Nakakido, Makoto, et al.
Publicado: (2016)

Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2016)

Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1
por: Bollu, Lakshmi Reddy, et al.
Publicado: (2020)

Identification of a novel p53 target, COL17A1, that inhibits breast cancer cell migration and invasion
por: Yodsurang, Varalee, et al.
Publicado: (2017)

Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2020)

p53-regulated autophagy is controlled by glycolysis and determines cell fate
por: Duan, Lei, et al.
Publicado: (2015)

Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells
por: Kato, Taigo, et al.
Publicado: (2016)

Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex
por: Fischer, Martin, et al.
Publicado: (2015)

cep-1/p53-dependent dysplastic pathology of the aging C. elegans gonad
por: McGee, Mathew D., et al.
Publicado: (2012)

Selected drugs that inhibit DNA methylation can preferentially kill p53 deficient cells
por: Yi, Lan, et al.
Publicado: (2014)

TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity
por: Chen, Dongshi, et al.
Publicado: (2014)

NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
por: Wu, Nan, et al.
Publicado: (2016)

p53 elevation in human cells halt SV40 infection by inhibiting T-ag expression
por: Drayman, Nir, et al.
Publicado: (2016)

Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity
por: Sriraman, Anusha, et al.
Publicado: (2016)

Loss of p53-inducible long non-coding RNA LINC01021 increases chemosensitivity
por: Kaller, Markus, et al.
Publicado: (2017)

Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
por: Tal, Perry, et al.
Publicado: (2016)

Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB
por: Hu, Ying, et al.
Publicado: (2015)

Addiction to Runx1 is partially attenuated by loss of p53 in the Eμ-Myc lymphoma model
por: Borland, Gillian, et al.
Publicado: (2016)

Similarity and difference in tumor-infiltrating lymphocytes in original tumor tissues and those of in vitro expanded populations in head and neck cancer
por: Ren, Lili, et al.
Publicado: (2017)

Genome-wide analysis of p53 transcriptional programs in B cells upon exposure to genotoxic stress in vivo
por: Tonelli, Claudia, et al.
Publicado: (2015)

Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging
por: Li, Tongyuan, et al.
Publicado: (2016)

Integrated analysis of somatic mutations and immune microenvironment of multiple regions in breast cancers
por: Kato, Taigo, et al.
Publicado: (2017)

Loss of p53 enhances the function of the endoplasmic reticulum through activation of the IRE1α/XBP1 pathway
por: Namba, Takushi, et al.
Publicado: (2015)

Mdm2 inhibition confers protection of p53-proficient cells from the cytotoxic effects of Wee1 inhibitors
por: Li, Yizhu, et al.
Publicado: (2015)

RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation
por: Yang, Jianqi, et al.
Publicado: (2016)

P73 tumor suppressor and its targets, p21 and PUMA, are required for madin-darby canine kidney cell morphogenesis by maintaining an appropriate level of epithelial to mesenchymal transition
por: Zhang, Yanhong, et al.
Publicado: (2015)

WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2016)

Small molecule restoration of wildtype structure and function of mutant p53 using a novel zinc-metallochaperone based mechanism
por: Yu, Xin, et al.
Publicado: (2014)

SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker
por: Kolukula, Vamsi K., et al.
Publicado: (2014)

Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage
por: Marzec, Kamila A., et al.
Publicado: (2015)

Drosophila melanogaster p53 has developmental stage-specific and sex-specific effects on adult life span indicative of sexual antagonistic pleiotropy
por: Waskar, Morris, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_6t3etd66sotns0m7mvclaepv28